Wolf‐Dieter Schleuning

5.2k total citations
88 papers, 4.4k citations indexed

About

Wolf‐Dieter Schleuning is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Wolf‐Dieter Schleuning has authored 88 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 28 papers in Cancer Research and 21 papers in Hematology. Recurrent topics in Wolf‐Dieter Schleuning's work include Protease and Inhibitor Mechanisms (26 papers), Blood Coagulation and Thrombosis Mechanisms (20 papers) and Signaling Pathways in Disease (11 papers). Wolf‐Dieter Schleuning is often cited by papers focused on Protease and Inhibitor Mechanisms (26 papers), Blood Coagulation and Thrombosis Mechanisms (20 papers) and Signaling Pathways in Disease (11 papers). Wolf‐Dieter Schleuning collaborates with scholars based in Germany, Switzerland and United States. Wolf‐Dieter Schleuning's co-authors include Bernard Haendler, Robert L. Medcalf, Egbert K. O. Kruithof, Peter Donner, Hans Fritz, Thomas Petri, Tze-Chein Wun, E. Reich, Jörn Krätzschmar and F Bachmann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Wolf‐Dieter Schleuning

88 papers receiving 4.1k citations

Peers

Countries citing papers authored by Wolf‐Dieter Schleuning

Since Specialization

Citations

This map shows the geographic impact of Wolf‐Dieter Schleuning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolf‐Dieter Schleuning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolf‐Dieter Schleuning more than expected).

Fields of papers citing papers by Wolf‐Dieter Schleuning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolf‐Dieter Schleuning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolf‐Dieter Schleuning. The network helps show where Wolf‐Dieter Schleuning may publish in the future.

Co-authorship network of co-authors of Wolf‐Dieter Schleuning

This figure shows the co-authorship network connecting the top 25 collaborators of Wolf‐Dieter Schleuning. A scholar is included among the top collaborators of Wolf‐Dieter Schleuning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolf‐Dieter Schleuning. Wolf‐Dieter Schleuning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tissue specificity of 8-prenylnaringenin: Protection from ovariectomy induced bone loss with minimal trophic effects on the uterus 2005 ·The Journal of Steroid Biochemistry and Molecular Biology ·M. Hümpel, (unknown), Olaf Schaefer, Ulrike Kaufmann, Paolo Ciana, Adriana Maggi, Wolf‐Dieter Schleuning	53
2	Both lysine-clusters of the NH2-terminal prion-protein fragment PrP23-110 are essential for t-PA mediated plasminogen activation 2004 ·Thrombosis and Haemostasis ·(unknown), (unknown), Michael Baier, Hermann−Georg Holzhütter, Eckart Köttgen, Reinhard Geßner, Wolf‐Dieter Schleuning, Michael Praus	21
3	A comparative study of amyloid-beta (1-42) as a cofactor for plasminogen activation by vampire bat plasminogen activator and recombinant human tissue-type plasminogen activator 2004 ·Thrombosis and Haemostasis ·Wolf‐Dieter Schleuning, Egbert K. O. Kruithof	9
4	Androgen receptor signalling: comparative analysis of androgen response elements and implication of heat-shock protein 90 and 14-3-3η 2001 ·Molecular and Cellular Endocrinology ·Bernard Haendler, (unknown), Wolf‐Dieter Schleuning	29
5	Vampire Bat Plasminogen Activator DSPA-Alpha-1 (Desmoteplase): A Thrombolytic Drug Optimized by Natural Selection 2001 ·Pathophysiology of Haemostasis and Thrombosis ·Wolf‐Dieter Schleuning	39
6	Expression of transcripts for cysteine-rich secretory proteins (CRISPs) in the murine lacrimal gland 1999 ·Journal of Cellular Physiology ·Bernard Haendler, Ikuko Toda, David A. Sullivan, Wolf‐Dieter Schleuning	29
7	Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. 1997 ·Journal of Clinical Investigation ·Berthold Hocher, Christa Thöne‐Reineke, Peter Rohmeiss, (unknown), Torsten Slowinski, Volker Burst, F Siegmund, Thomas Quertermous, C. Bauer, H.-H. Neumayer, Wolf‐Dieter Schleuning, Franz Theuring	345
8	cDNA cloning of two closely related forms of human germ cell nuclear factor (GCNF) 1997 ·Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·(unknown), Jörn Krätzschmar, Manfred Husemann, Wolf‐Dieter Schleuning	26
9	CRISP-3, a Protein with Homology to Plant Defense Proteins, Is Expressed in Mouse B Cells under the Control of Oct2 1996 ·Molecular and Cellular Biology ·Petra Pfisterer, Harald König, Jochen Heß, (unknown), Bernard Haendler, Wolf‐Dieter Schleuning, Thomas Wirth	59
10	A general route to fingerprint analyses of peptide-antibody interactions using a clustered amino acid peptide library: Comparison with a phage display library 1995 ·Molecular Immunology ·Achim Kramer, Evangelia Vakalopoulou, Wolf‐Dieter Schleuning, Jens Schneider‐Mergener	25
11	Triabin, a Highly Potent Exosite Inhibitor of Thrombin 1995 ·Journal of Biological Chemistry ·Christiane Noeske‐Jungblut, Bernard Haendler, Peter Donner, Alejandro Alagón, Lourival D. Possani, Wolf‐Dieter Schleuning	121
12	Splice Variants of the Human EP3 Receptor for Prostaglandin E2 1995 ·European Journal of Biochemistry ·Andrea Schmid, Karl‐Heinz Thierauch, Wolf‐Dieter Schleuning, Harald Dinter	81
13	Primary structure and properties of helothermine, a peptide toxin that blocks ryanodine receptors 1995 ·Biophysical Journal ·Jeffery M. Morrissette, Jörn Krätzschmar, Bernard Haendler, Roque El-Hayek, Javier Mochca-Morales, Brian M. Martin, (unknown), Richard L. Moss, Wolf‐Dieter Schleuning, Roberto Coronado	142
14	Induction of c‐fos gene expression by urokinase‐type plasminogen activator in human ovarian cancer cells 1994 ·FEBS Letters ·Inna Dumler, Thomas Petri, Wolf‐Dieter Schleuning	57
15	Expression of Human Endothelin Receptor ETB by Escherichia coli Transformants 1993 ·Biochemical and Biophysical Research Communications ·Bernard Haendler, (unknown), Andreas Becker, Wolf‐Dieter Schleuning	12
16	Interaction of urokinase‐type plasminogenactivator (u‐PA) with its cellular receptor (u‐PAR) induces phosphorylation on tyrosine of a 38 kDa protein 1993 ·FEBS Letters ·Inna Dumler, Thomas Petri, Wolf‐Dieter Schleuning	86
17	Tumor necrosis factor α increases antifibrinolytic activity of cultured human mesangial cells 1992 ·Kidney International ·Q. Meulders, Cijiang He, Colette Adida, Marie-Noëlle Peraldi, Wolf‐Dieter Schleuning, Jean–Daniel Sraer, Éric Rondeau	27
18	Allelic dimorphism in the human tissue-type plasminogen activator (TPA) gene as a result of an Alu insertion/deletion event 1992 ·Human Genetics ·Michael Ludwig, (unknown), Wolf‐Dieter Schleuning, K. Olek	43
19	Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes. 1988 ·The Journal of Experimental Medicine ·Robert L. Medcalf, Egbert K. O. Kruithof, Wolf‐Dieter Schleuning	86
20	Some Characteristics of Highly Purified Boar Sperm Acrosin 1974 ·Biological Chemistry ·Wolf‐Dieter Schleuning, Hans Fritz	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact